Advertisement Rockwell Medical inks supply pact with DaVita - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Rockwell Medical inks supply pact with DaVita

Rockwell Medical has entered into a multi-year supply pact with DaVita, a provider of kidney care in the US.

Rockwell Medical is a biopharmaceutical company that offers products and services initially targeting end-stage renal disease (ESRD), chronic kidney disease (CKD) and iron deficiency anemia.

The company is engaged in developing a proprietary renal drug therapy for treating iron deficiency in ESRD patients on dialysis.

Rockwell Medical chairman and CEO Robert Chioini said they are pleased to have executed this multi-year supply agreement with DaVita, further strengthening their business relationship.